{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:29:51Z","timestamp":1786375791973,"version":"build-2736575974"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec id=\"ab-noi260039-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Ebola virus disease (EVD) causes multiorgan damage and is highly fatal. EVD\u2019s neurological impact among survivors remains poorly characterized due to limited neurological assessment capabilities in the remote regions where most outbreaks occur.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260039-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize neurological sequelae in EVD survivors over more than 7 years\u2019 longitudinal follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260039-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Under the Ebola Natural History Study (PREVAIL III; PIII), the Neurology Study of PIII was a prospective longitudinal cohort study in Liberia of adult Ebola survivors and control individuals conducted from September 2015 to March 2023 at the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) site at John F. Kennedy Medical Center in Monrovia, Liberia. Data were analyzed from April 2023 to September 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260039-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Neurological evaluations were performed by trained neurologists biannually. Questionnaire and neurological examination data were collected on case report forms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260039-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Neurological symptom prevalence and neurological examination scores were compared to those of control individuals. Tests for differences between survivors and control individuals were conducted using generalized linear mixed-effects models controlling for age and sex. Overdispersed Poisson models were used to test for computed neurological examination score differences. Neurological examination scores were developed for this study, representing the cumulative abnormalities on neurological examinations, denoted on standardized case report forms, with the general neurological examination score representing all examination abnormalities and the central nervous system score representing the central nervous system\u2013specific abnormalities on examination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260039-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Analysis after serologic testing included 148 Ebola antibody-positive survivors (mean [SD] age, 34.8 [10.5] years; 74 [50%] female) and 81 antibody-negative contacts (mean [SD] age, 35.8 [12.6] years; 41 [51%] female). During acute infection, survivors reported headaches, altered mental status, and strokelike symptoms or meningoencephalitis (rarely). Survivors had significant neurological sequelae involving the entire neuraxis: cognitive dysfunction (83 [56.1%]), persistent headaches (98 [66.2%]), sleep abnormalities (40 [27.0%]), depression (73 [49.3%]), sexual dysfunction (48 [32.4%]), tremor (18 [20.3%]), fatigue (71 [51.1%]), cranial nerve abnormalities (60 [40.5%]), and sensory abnormalities (45 [30.4%]). Over 7 years\u2019 follow-up, most survivors demonstrated improvement in neurological status. The final visit included 115 survivors (77.7%) and 61 close contacts (75.3%). Persistent symptoms at final evaluation in survivors compared to contacts were memory loss (66 [57.4%] vs 16 [26.2%], respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), irritability (42 [36.5%] vs 9 [14.8%], respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.006), and trouble concentrating (34 [29.6%] vs 6 [9.8%], respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260039-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The findings indicate that Ebola virus infection is associated with neurological complications in survivors, with increased health care burden and socioeconomic consequences. These neurological issues generally improved with time, but some persisted long-term. Close neurological follow-up of EVD survivors may be warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2026.2112","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:44Z","timestamp":1781105444000},"page":"739","source":"Crossref","is-referenced-by-count":1,"title":["Neurological Manifestations in Adult Survivors of Ebola Virus Disease"],"prefix":"10.1001","volume":"83","author":[{"given":"Bridgette Jeanne","family":"Billioux","sequence":"first","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cavan","family":"Reilly","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"van Ryn","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Smith","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"},{"name":"DC Veterans Affairs Medical Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tarfeh-Burnette","sequence":"additional","affiliation":[{"name":"Liberia College of Physicians and Surgeons, Monrovia, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Dorbor","sequence":"additional","affiliation":[{"name":"Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korlia","family":"Bonarwolo","sequence":"additional","affiliation":[{"name":"Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Taryor","sequence":"additional","affiliation":[{"name":"Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"Schindler","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Neurology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren Bowen","family":"Reoma","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shila","family":"Azodi","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"},{"name":"US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Ohayon","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Enose-Akahata","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bishop","sequence":"additional","affiliation":[{"name":"National Eye Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Johns Hopkins Medicine Wilmer Eye Institute, Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Higgs","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Clifford","family":"Lane","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumblytee","family":"Johnson","sequence":"additional","affiliation":[{"name":"Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Sneller","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosoka","family":"Fallah","sequence":"additional","affiliation":[{"name":"Africa Center for Disease Control and Prevention, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"noi260039r2","first-page":"247","article-title":"Ebola haemorrhagic fever in Sudan, 1976. report of a WHO\/International Study Team.","volume":"56","author":"WHO\/International Study Team","year":"1978","journal-title":"Bull World Health Organ"},{"key":"noi260039r3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.","volume":"179","author":"Bwaka","year":"1999","journal-title":"J Infect Dis"},{"key":"noi260039r4","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1086\/514297","article-title":"Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995.","volume":"179","author":"Ndambi","year":"1999","journal-title":"J Infect Dis"},{"key":"noi260039r5","doi-asserted-by":"publisher","first-page":"S790","DOI":"10.1093\/clinids\/11.Supplement_4.S790","article-title":"Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire.","volume":"11","author":"Sureau","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"1","key":"noi260039r6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00003246-200001000-00041","article-title":"Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.","volume":"28","author":"Richards","year":"2000","journal-title":"Crit Care Med"},{"issue":"8","key":"noi260039r7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","article-title":"Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study.","volume":"15","author":"Clark","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"noi260039r8","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Clinical illness and outcomes in patients with Ebola in Sierra Leone.","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"noi260039r9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/cid\/civ319","article-title":"Clinical features of patients with Ebola virus disease in Sierra Leone.","volume":"61","author":"Qin","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"noi260039r10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.7326\/M15-3066","article-title":"Severe meningoencephalitis in a case of Ebola virus disease: a case report.","volume":"165","author":"Chertow","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"noi260039r11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3201\/eid2201.151212","article-title":"Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone.","volume":"22","author":"Howlett","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"noi260039r12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-211062","article-title":"Surviving stroke in an Ebola Treatment Centre.","author":"Dhillon","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"8","key":"noi260039r13","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3201\/eid2408.171367","article-title":"Case series of severe neurologic sequelae of Ebola virus disease during epidemic, Sierra Leone.","volume":"24","author":"Howlett","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"noi260039r14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/cid\/civ453","article-title":"Study of Ebola virus disease survivors in Guinea.","volume":"61","author":"Qureshi","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"25","key":"noi260039r15","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1056\/NEJMc1506576","article-title":"Post-Ebola signs and symptoms in U.S. survivors.","volume":"373","author":"Epstein","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"noi260039r16","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/cid\/ciw158","article-title":"Ebola virus disease complications as experienced by survivors in Sierra Leone.","volume":"62","author":"Tiffany","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"noi260039r17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","article-title":"Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.","volume":"16","author":"Mattia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10043","key":"noi260039r18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","article-title":"Late Ebola virus relapse causing meningoencephalitis: a case report.","volume":"388","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"noi260039r19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1805435","article-title":"A longitudinal study of Ebola sequelae in Liberia.","volume":"380","author":"Sneller","year":"2019","journal-title":"N Engl J Med"},{"issue":"23","key":"noi260039r20","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/WNL.0b013e318258f744","article-title":"Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.","volume":"78","author":"Cella","year":"2012","journal-title":"Neurology"},{"issue":"15","key":"noi260039r21","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia.","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"noi260039r22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/infdis\/jiv357","article-title":"Necrotizing scleritis, conjunctivitis, and other pathologic findings in the left eye and brain of an Ebola virus-infected rhesus macaque (Macaca mulatta) with apparent recovery and a delayed time of death.","volume":"213","author":"Alves","year":"2016","journal-title":"J Infect Dis"},{"issue":"12","key":"noi260039r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209655","article-title":"Surviving Ebola: a historical cohort study of Ebola mortality and survival in Sierra Leone 2014.","volume":"13","author":"Wing","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"noi260039r24","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200097","article-title":"Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection.","volume":"10","author":"Mina","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"noi260039r25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41467-024-45107-3","article-title":"Deep phenotyping of post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome.","volume":"15","author":"Walitt","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"noi260039r26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/acn3.70031","article-title":"Clinical phenotyping of long COVID patients evaluated in a specialized neuro-COVID clinic.","volume":"12","author":"Yamashita","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"noi260039r27","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit.","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"},{"issue":"15","key":"noi260039r28","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation.","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"noi260039r29","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/infdis\/jiaa268","article-title":"Ebola-specific CD8+ and CD4+ T-cell responses in Sierra Leonean Ebola virus survivors with or without post-Ebola sequelae.","volume":"222","author":"LaVergne","year":"2020","journal-title":"J Infect Dis"},{"issue":"3","key":"noi260039r30","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1093\/cid\/ciac424","article-title":"Risk factors for Ebola virus persistence in semen of survivors in Liberia.","volume":"76","author":"Dyal","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"9","key":"noi260039r31","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamaneurol.2017.1460","article-title":"Cerebrospinal fluid examination in survivors of Ebola virus disease.","volume":"74","author":"Billioux","year":"2017","journal-title":"JAMA Neurol"},{"issue":"6","key":"noi260039r32","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/cid\/ciab267","article-title":"Post-Ebola syndrome presents with multiple overlapping symptom clusters: evidence from an ongoing cohort study in Eastern Sierra Leone.","volume":"73","author":"Bond","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"noi260039r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101033","article-title":"Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control study.","volume":"6","author":"Fallah","year":"2025","journal-title":"Lancet Microbe"},{"issue":"10","key":"noi260039r34","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00137-X","article-title":"Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study.","volume":"5","author":"Mukadi-Bamuleka","year":"2024","journal-title":"Lancet Microbe"},{"issue":"1","key":"noi260039r35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12888-021-03343-7","article-title":"PTSD, depression and anxiety in Ebola virus disease survivors in Beni town, Democratic Republic of the Congo.","volume":"21","author":"Kaputu-Kalala-Malu","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"1","key":"noi260039r36","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1186\/s12889-020-09507-6","article-title":"Prevalence of anxiety, depression and post-traumatic stress disorder among Ebola survivors in northern Sierra Leone: a cross-sectional study.","volume":"20","author":"Bah","year":"2020","journal-title":"BMC Public Health"},{"issue":"9","key":"noi260039r37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004113","article-title":"Prognostic analysis of patients with Ebola virus disease.","volume":"9","author":"Zhang","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"noi260039r38","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/infdis\/jiv304","article-title":"The contribution of Ebola viral load at admission and other patient characteristics to mortality in a M\u00e9decins Sans Fronti\u00e8res Ebola case management centre, Kailahun, Sierra Leone, June-October 2014.","volume":"212","author":"Fitzpatrick","year":"2015","journal-title":"J Infect Dis"},{"issue":"16","key":"noi260039r39","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","article-title":"Ebola virus disease in West Africa\u2013the first 9 months of the epidemic and forward projections.","volume":"371","author":"Aylward","year":"2014","journal-title":"N Engl J Med"},{"key":"noi260039r1","unstructured":"World Health Organization. Ebola situation report 30 March 2016. Accessed November 15, 2018. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/c5ba391b-bb01-4933-b39c-8be9b5fd8b6e\/content"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2850237\/jamaneurology_billioux_2026_oi_260039_1786107776.61301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:00:29Z","timestamp":1786374029000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2850237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2026.2112","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}